Evaluating the Bioactivity of a Novel Antimicrobial and Anticancer Peptide, Dermaseptin-PS4(Der-PS4), from the Skin Secretion of Phyllomedusa sauvagii by Chen, Dong et al.
Evaluating the Bioactivity of a Novel Antimicrobial and Anticancer
Peptide, Dermaseptin-PS4(Der-PS4), from the Skin Secretion of
Phyllomedusa sauvagii
Chen, D., Zhou, X., Chen, X., Huang, L., Xi, X., Ma, C., ... Chen, T. (2019). Evaluating the Bioactivity of a Novel
Antimicrobial and Anticancer Peptide, Dermaseptin-PS4(Der-PS4), from the Skin Secretion of Phyllomedusa
sauvagii. Molecules, 1-22. https://doi.org/10.3390/molecules24162974
Published in:
Molecules
Document Version:
Publisher's PDF, also known as Version of record
Queen's University Belfast - Research Portal:
Link to publication record in Queen's University Belfast Research Portal
Publisher rights
Copyright 2019 the authors.
This is an open access article published under a Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/),
which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.
General rights
Copyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other
copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated
with these rights.
Take down policy
The Research Portal is Queen's institutional repository that provides access to Queen's research output. Every effort has been made to
ensure that content in the Research Portal does not infringe any person's rights, or applicable UK laws. If you discover content in the
Research Portal that you believe breaches copyright or violates any law, please contact openaccess@qub.ac.uk.
Download date:16. Sep. 2019
molecules
Article
Evaluating the Bioactivity of a Novel Antimicrobial
and Anticancer Peptide, Dermaseptin-PS4(Der-PS4),
from the Skin Secretion of Phyllomedusa sauvagii
Dong Chen 1,†, Xiaowei Zhou 1,2,†, Xi Chen 1, Linyuan Huang 1,3,*, Xinping Xi 1,*,
Chengbang Ma 1, Mei Zhou 1 , Lei Wang 1 and Tianbao Chen 1
1 Natural Drug Discovery Group, School of Pharmacy, Queen’s University, Belfast BT9 7BL, UK
2 Department of Nutrition, Henry Fok School of Food Science and Engineering, Shaoguan University,
Shaoguan 512005, China
3 School of Life Sciences and Technology, China Pharmaceutical University, Nanjing 211198, China
* Correspondence: huangly@cpu.edu.cn (L.H.); x.xi@qub.ac.uk (X.X.);
Tel.: +86-185-5227-1881 (L.H.); +44-28-9097-1673 (X.X.)
† Theses authors contributed equally to this work.
Received: 25 July 2019; Accepted: 15 August 2019; Published: 16 August 2019


Abstract: Dermaseptins belonging to a large family of cationic membrane-disruption antimicrobial
peptides display extensive antibacterial and antiproliferative activities depending on a coil-to-helix
transition and the specific structural parameters. Herein, a novel dermaseptin peptide named
Der-PS4 was discovered from the skin secretion of the waxy monkey tree frog, Phyllomedusa sauvagii.
The complementary DNA (cDNA)-encoding precursor was obtained relying on “shotgun” cloning,
and afterwards, a mature peptide amino acid sequence was identified by reverse-phase high
performance liquid chromatography (RP-HPLC) and MS/MS. Specimens were chemically synthesized
and applied for further functional studies. Structural analysis demonstrated a higher α-helical
content in the membrane-mimetic environment compared with that in the ammonium acetate/water
circumstance. Der-PS4 displayed a broad spectrum of antimicrobial activities against tested pathogenic
microorganisms, however, exhibiting slight membrane-damaging effectiveness towards horse red
blood cells. Coincident with the inhibitory activities on pathogens, Der-PS4 also showed considerable
biofilm eradicating impact. Also, Der-PS4 penetrated cell membrane in a relative short period under
each minimum bactericidal concentration. In addition, Der-PS4 possessed antiproliferative capacity
against five cancer cell lines, while presenting slight suppressing effect on human microvascular
endothelial, HMEC-1. These findings provide a promising insight for the discovery and development
of novel drugs from a natural source.
Keywords: dermaseptin; molecular cloning; antimicrobial peptide; anticancer peptide; frog skin secretion
1. Introduction
The host-defense peptides isolated from anura (frog and toad) skins have promising therapeutic
applications and have attracted much attention owing to their multiple biological activities. This
abundant natural product resource shows multiple physiological and pathological functions in the form
of bactericidal, antiproliferative, immunoregulatory, and antidiabetic properties [1]. Actually, these
kinds of host-defense peptides not only exist in frog species but also can be discovered from human
bodies, microorganisms, and plants [2]. The existence of frog skins and secretions are always considered
as the first barrier for these creatures to defend against predators or protecting them from invading
microbes in the environment [3]. Recent research suggests that symbiotic bacteria on skins play a
more important role for survival, while host-defense peptides may act as innate immunomodulators to
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assist symbiotic bacteria to defend against pathogens in some species [1,4,5]. The peptides isolated
from frog skins vary in size from a minimum of eight residues to a maximum of forty-eight residues.
Some mutual physicochemical properties, including a cationic charge, amphipathicity, and α-helical
structures are ubiquitous. However, structural studies suggest that more α-helical content would be
observed in the membrane-mimetic environment which may provide support for the combination with
cellular phospholipid membrane [6]. At the genetic level, highly conserved signal peptide sequences
with a particular amino acid replacement and consensus motif in one peptide family from widely
distributed frog species may offer some hint at evolutionary processes [7,8].
Dermaseptins, in a narrow sense, refers to a family of antimicrobial or tumouricidal peptides with
highly conserved signal sequences and several consensus motifs in mature sequences isolated from the
skin or skin secretions of Hylidae and Ranidae frogs [9]. The first dermaseptin, a 34-mer polypeptide
named Dermaseptin-S1, was identified from the dried skin of the waxy monkey tree frog, Phyllomedusa
sauvagii, by Mor and co-workers in 1991 [10]. Followed by functional study, Dermaseptin-S1 exhibited
fatal activity against filamentous fungi, which acted as the first gene-coding eukaryotic anti-fungal
peptide [9]. On the whole, the prototype members of this family have typical coil-to-helix structures
with cationic charge which could facilitate the combination with the anionic membranes, causing
penetration and disruption of microorganisms [9,11]. However, the low toxicity to mammalian cells of
dermaseptins provide a new concept of membrane selectivity of Dermaseptins. Few years after the
discovery of Dermaeptin-S1, another novel peptide named Dermaseptin B2 was identified from the
skin of Phyllomedusa bicolor, which was an adenoregulin interacting with the adenosine receptor. Owing
to the different functions, these two peptides were considered unrelated until the prepropeptides
were cloned, which revealed the connection between these two polypeptides according to the highly
conserved sequences [12–14]. From then on, identifying dermaseptins based on molecular cloning,
common regions were constructed, and the dermaseptin family increased progressively. For instance,
Dermaseptin-PH and Dermaseptin-PS3 (Der-PS3) were identified from the skin secretion of Pitheocopus
(Phyllomedusa) hypochondrialis and Phyllomedusa sauvagii, respectively [15,16].
In this present study, a novel antimicrobial and anticancer peptide named Dermaseptin-PS4
(Der-PS4) was isolated from the skin secretion of the waxy monkey tree frog, Phyllomedusa sauvagii.
The cDNA encoding biosynthetic precursor was identified by “shotgun” cloning and the amino acid
sequence was confirmed by RP-HPLC and mass spectrum (MS/MS) fragmentation sequencing via
analyzing the crude skin secretions. Der-PS4 applied in functional studies was chemically synthesized
by solid-phase peptide synthesis (SPPS) technique. Subsequently, synthetic Der-PS4 was subjected to
antimicrobial susceptibility tests by utilizing Gram-positive and Gram-negative bacteria, and fungus.
An antiproliferative assay was performed to evaluate the anticancer activities of Der-PS4 against five
human cancer cell lines. A haemolysis test and human dermal microvascular endothelium cells were
performed to evaluate the cytotoxicity of Der-PS4 against eukaryotic cells.
2. Results
2.1. Molecular Cloning and Structural Characterisation of Der-PS4 from a Skin Secretion-Derived cDNA
Library of Phyllomedusa sauvagii
A cDNA encoding biosynthetic precursor of Der-PS4 was identified from the cDNA library with
the assistance of a specific degenerate primer designed based on the highly conserved sequence of
dermaseptins. The translated open reading frame of Der-PS4 consisted of 340 base pairs encoding 76
amino acids including a highly conserved hydrophobic signal peptide domain of 22 amino acid residues,
an acidic spacer containing 16 amino acids and a representative Lys-Arg processing site followed by the
predicted mature peptide Der-PS4 comprising 28 amino acids (Figure 1). A consensus motif -GEQ after
the mature peptide region estimated a C-terminal post-translational amide modification by comparing
the sequences published. The nucleotide biosynthetic precursor of Der-PS4 was submitted to the
GenBank Database (https://www.ncbi.nlm.nih.gov/genbank/) under the accession number MK256942.
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identified by molecular cloning was indicated by an arrow. The amino acid sequence of Der-PS4 was 
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MS/MS fragmentation sequencing technique and result was shown in Figure 3. The predicted post-
translational amidation of Der-PS4 with -GEQ residues at C-terminus of biosynthetic precursor was 
also confirmed in the result. 
 
Figure 1. Nucleotide sequence and related open-reading frame of Der-PS4 from the skin secretion of 
Phyllomedusa sauvagii. The putative signal peptide is double-underlined, the mature peptide is single-
underlined and the stop codon is marked by an asterisk. 
Figure 1. Nucleotide sequence and related open-reading frame of Der-PS4 from the skin secretion
of Phyllomedusa sauvagii. The putative signal peptide is double-underlined, the mature peptide is
single-underlined and the stop codon is marked by an asterisk.
The expected mature peptide, Der-PS4, was eluted from reverse-phase HPLC by analyzing the
lyophilized crude skin secretion of Phyllomedusa sauvagii (Figure 2). Fractions collected every minute
were analyzed by MALDI-TOF-MS and the one with a mass corresponding to the mature peptide
identified by molecular cloning was indicated by an arrow. The amino acid sequence of Der-PS4 was
further verified by analyzing the fraction containing estimated peptide mass through utilizing MS/MS
fragmentation sequencing technique and result was shown in Figure 3. The predicted post-translational
amidation of Der-PS4 with -GEQ residues at C-terminus of biosynthetic precursor was also confirmed
in the result.
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Figure 2. Reverse-phase HPLC chromatogram of lyophilized skin secretion of Phyllomedusa sauvagii. 
The arrow indicates the retention time/elution position of the fraction containing a mass 
corresponding to the predicted mature peptide. The absorbance was measured at λ = 214 nm and λ = 
280 nm. The X-axis indicates the retention time in minutes and the Y-axis indicates the absorbance in 
arbitrary units. 
Figure 2. Reverse-phase HPLC chromatogram of lyophilized skin secretion of Phyllomedusa sauvagii.
The arrow indicates the retention time/elution position of the fraction containing a mass corresponding
to the predicted mature peptide. The absorbance was measured at λ = 214 nm and λ = 280 nm. The
X-axis indicates the retention time in minutes and the Y-axis indicates the absorbance in arbitrary units.
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Figure 3. Electrospray ion-trap MS/MS fragmentation data derived from fragment ions corresponding 
to molecular mass to Der-PS4. Predicted singly and doubly charged b-ions and y-ions are in black 
typeface. Ions detected by MS/MS fragmentation are indicated in red and blue. 
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Der-PS4 displayed strong α-helical conformations of 67.6% (TFE/ammonium acetate), 62% 
(DOPC/DOPG, 1/1) and 77.3% (DOPE/DOPG, 1/1), which indicated Der-PS4 displayed more α-helical 
content in the membrane-mimetic environment. What’s more, the α-helical wheel plots and 
physicochemical properties were estimated by Heliquest in Figure 4b and Table 1. The 
hydrophobicity of Der-PS4 was 0.368 and the hydrophobic moment was 0.358. With four basic amino 
acids, lysine, and one acidic amino acid, asparticacid, the final net charge was +3. The hydrophobic 
face of Der-PS4 was predicted by arrow in Figure 4b and consisted with Trp (tryptophan), Ala 
(alanine), Ala, Leu (leucine), Met (methionine) and Ala. The proportion of polar residues was 46.43% 
comprising eight uncharged residues and five charged residues. 
Figure 3. Electrospray ion-trap MS/MS fragmentation data derived from fragment ions corresponding
to molecular mass to Der-PS4. Predicted singly and doubly charged b-ions and y-ions are in black
typeface. Ions detected by MS/MS fragmentation are indicated in red and blue.
, - t r l ti iff t ti f , .
). Der-PS4 was unable t form α-helical str cture in ammonium acetate s lution with
he ix value of 4.1. Howev r, in the TFE/a monium acetate solution and me brane mimicking
liposomes, Der-PS4 displayed strong α-helical conformations of 67.6% (TFE/am onium acetate),
62% (DOPC/DOPG, 1/1) and 77.3% ( E/DOPG, 1/1), which indicated Der-PS4 isplayed more
α-helical content in the membran -mimet c e vironment. What’s more, the α-helical wheel plots
ical properties were estima ed by Heliquest in Figure 4b and Table 1. The hydrophobicity
of Der-PS4 was 0.368 and the hydrophobic moment was 0.358. With four basic amino acids, lysine, a d
one acidic amino acid, sparticacid, the final net charge was +3. The hydrophobic face of Der-PS4 was
predicted by arro in Figure 4b and consisted with Trp (tryptophan), Ala (alanine), Ala, Leu (leucine),
Met (m thionine) and Ala. The proport of polar residues was 46.43% comprising eight uncharged
residue and five charged residues.
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Figure 4. The CD spectra recorded for Der-PS4 in ammonium acetate, 50% TFE/ammonium acetate 
and membrane mimicking liposomes (a). The helical wheel projections of Der-PS4 with an arrow 
indicated the hydrophobic face (b). 
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(Figure 5) and MBCs in a range from 8 to 32 µM. For Gram-positive bacteria, Der-PS4 exhibited more 
effective antimicrobial activity against S. aureus and drug-resistant bacterium MRSA with MICs of 4 
µM and 8 µM. While, the MIC and MBC of E. faecalis were both 32 µM. Although ampicillin showed 
more efficient antibacterial ability than Der-PS4 on S. aureus and E. faecalis, it showed no obvious 
inhibiting effect on MRSA. For Gram-negative bacteria and fungus, Der-PS4 was more efficiency than 
ampicillin, but weaker than norfloxacin. The MICs and MBCs of melittin were displayed below as a 
relevant control. Additionally, it was worth noting that although Der-PS4 showed relative 50% 
haemolyltic activity at around concentration of 128 µM, it displayed slight haemolysis at MICs 
(Figure 6). 
Table 2. MICs and MBCs of Der-PS4, ampicillin and norfloxacin. 
Drugs 
MIC/MBC (μM) 
S. aureus MRSA E. faecalis E. coli P. aeruginosa C. albicans 
Der-PS4 4/8 8/16 32/32 8/16 16/32 4/16 
Melittin 2/2 2/4 2/2 2/4 32/32 4/4 
Ampicillin 0.3/0.3 - 4.8/4.8 36.6/36.6 - 146/- 
Norfloxacin 1.3/2.5 2.5/5.2 5.2/5.2 0.6/0.6 2.5/5.2 1.3/2.5 
Figure 4. The CD spectra recorded for Der-PS4 in ammonium acetate, 50% TFE/ammonium acetate and
membrane mimicking liposomes (a). The helical wheel projections of Der-PS4 with an arrow indicated
the hydrophobic face (b).
Table 1. Structural parameters of Der-PS4.
Der-PS4: 1ALWKTLLKHVGKAAGKAALNAVTDMVNQ28
Physico-Chemical
Properties
Hydrophobicity (H)
0.368
Hydrophobic Moment <µH>
0.226
Net Charge
3
Polar residues
+ GLY
Polar residues + GLY (n/%)
13/46.43
Uncharged residues + GLY
GLN 1, HIS 1, THR 2, ASN 2,
GLY 2
Charged residues
LYS 4, ASP 1
Nonpolar
residues
Nonpolar residues (n/%)
15/53.57
Aromatic residues
TRP 1
Special residues
CYS 0, PRO 0
Hydrophobic face: W A A L M A
2.3. Antimicrobial Minimal Inhibitory Concentrati n Assay
The data derived from minimum inhibitory concentrations (MICs) and minimum bactericidal
concentrations (MBCs) of synthetic peptide Der-PS4, melittin, ampicillin and norfloxacin were
summarized in Table 2. Der-PS4 was verified to h ve d fferent antimicrobial activities against
Gram-positi bacteria Staphylococcus aure s (ATCC 12600), MRSA (ATCC B A-1720), Enterococcus
faecalis (ATCC 29212), Gram-negative bacteria Escherichia coli (ATCC 11755), Pseudomonas aeruginosa
(ATCC 27853), and pathogenic fungus Candida albicans (ATCC 10231), with MICs ranging from
4 to 32 µM (Figure 5) and MBCs in a range from 8 to 32 µM. For Gram-positive bacteria, Der-PS4
exhibited more effective antimicrobial activity against S. aureus and drug-resistant bacterium MRSA
with MICs f 4 µM and 8 µM. While, the MIC and MBC of E. faecalis were both 32 µ . Although
ampicillin showed more efficient antibacterial ability than Der-PS4 on S. aureus and E. faecalis, it showed
no obvious inhibiting effect on MRSA. For Gram-negative bacteria and fungus, Der-PS4 was more
efficiency than ampicillin, but weaker than norfloxacin. The MICs and MBCs of melittin were displayed
below as a relevant control. Additionally, it was worth noting that although Der-PS4 showed relative
50% haemolyltic activity at around concentration of 128 µM, it displayed slight haemolysis at MICs
(Figure 6).
Table 2. MICs and MBCs of Der-PS4, ampicillin and norfloxacin.
Drugs MIC/MBC (µM)
S. aureus MRSA E. faecalis E. coli P. aeruginosa C. albicans
Der-PS4 4/8 8/16 32/32 8/16 16/32 4/16
Melittin 2/2 2/4 2/2 2/4 32/32 4/4
Ampicillin 0.3/0.3 - 4.8/4.8 36.6/36.6 - 146/-
Norfloxacin 1.3/2.5 2.5/5.2 5.2/5.2 0.6/0.6 2.5/5.2 1.3/2.5
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Figure 5. Minimum inhibitory concentrations (MICs) curves obtained following incubation of Der-
PS4 with S. aureus (a), MRSA (b), E. faecalis (c), E. coli (d), P. aeruginosa (e) and C. albicans (f) in a range 
of concentrations from 1 µM to 512 µM. Data represent means ± SEM (standard error of the mean) of 
5 replicates. 
Figure 5. Minimum inhibitory concentrations (MICs) curves obtained following incubation of Der-PS4
with S. aureus (a), MRSA (b), E. faecalis (c), E. coli (d), P. aeruginosa (e) and C. albicans (f) in a range of
concentrations from 1 µM to 512 µM. Data represent means ± SEM (standard error of the mean) of
5 replicates.
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buffer. Data represent means ± SEM (standard error of the mean) of 5 replicates. 
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Der-PS4 displayed stronger permeability on S. aureus and MRSA than on E. faecalis. At the 
concentration of 8 µM, cell membrane of S. aureus was fully disruptive and that of MRSA was 
approximately seventy percent permeabilized. However, E. faecalis showed no significant 
permeability rate compared to the negative control under the concentration of 8 µM. One hundred 
percent of permeability rate reached until 64 µM of Der-PS4 was administrated. For Gram-negative 
bacteria, the penetration capacity of Der-PS4 was more powerful on E. coli than on P. aeruginosa, with 
complete penetration under the concentration of 8 µM on E. coli and 32 µM on P. aeruginosa. For 
fungus C. albicans, full permeabilization was obtained under the concentration of 16 µM. 
What’s more, the real-time dynamic permeable trend was collected on three representative 
microorganisms, S. aureus, E. coli and C. albicans (Figure 8). Coincident with the end-point results, the 
efficiently complete permeabilization of Der-PS4 on S. aureus and E. coli was both 8 µM. However, 
it’s worth noting that, although Der-PS4 exhibited identical permeable activities on these two 
Figure 6. The haemolysis activity of Der-PS4 was tested using horse red blood cells in a range of
concentrations from 1 µM to 512 µM. Positive control group was treated with 1% Triton X-100 lysis
buffer. Data represent means ± SEM (standard error of the mean) of 5 replicates.
2.4. Anti-Biofilm Activity of Der-PS4
Synthetic peptide Der-PS4 exhibited anti-biofilm activity against several microorganisms including
Gram-positive bacteria and Gram-negative bacteria (Table 3). The MBIC results of Der-PS4 on S. aureus,
MRSA and E. coli were coincident with the MIC results, with 4, 8, and 8 µM each. However, the MBIC
values on E. faecalis and P. aeruginosa were two times higher than their MIC results, with concentrations
of 64 and 32 µM, respectively. For the biofilm eradicating activity, eight times higher values than MBIC
values on MRSA and P. aeruginosa were obtained. For E. faecalis and E. coli, the MBEC results were two
ti es and four times higher than MBICs, with 128 µM and 32 µM respectively. However, the MBEC
value of S. aureus was 64 µM, which was sixteen times higher than its MBIC value.
Table 3. The minimum biofilm inhibitory concentrations (MBICs) and minimum biofilm eradication
concentrations (MBEC) of Der-PS4.
S. aureus MRSA E. faecalis E. coli P. aeruginosa
MBIC (µM) 4 8 64 8 32
MBEC (µM) 64 64 128 32 256
2.5. Bacteria Cell Membrane Permeabilized Activity of Der-PS4
The permeabilization activities of Der-PS4 were evaluated in a range of concentrations on bacteria
and fungus. Melittin was acted as a relevant control (Figure 7). For Gram-positive bacteria, Der-PS4
displayed stronger permeability on S. aureus and MRSA than on E. faecalis. At the concentration of
8 µM, cell membrane of S. aureus was fully disruptive and that of MRSA was approximately seventy
percent permeabilized. However, E. faecalis showed no significant permeability rate compared to the
negative control under the concentration of 8 µM. One hundred percent of permeability rate reached
until 64 µM of Der-PS4 was administrated. For Gram-negative bacteria, the penetration capacity of
Der-PS4 was more powerful on E. coli than on P. aeruginosa, with complete penetration under the
concentration of 8 µM on E. coli and 32 µM on P. aeruginosa. For fungus C. albicans, full permeabilization
was obtained under the concentration of 16 µM.
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incubation with 5% tryptic soy broth (TSB) in 0.85% NaCl. Positive control was acquired after 
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Figure 7. The permeabilization activities of Der-PS4 were evaluated on S. aureus (a), MRSA (b), E. faecalis
(c), E. coli (d), P. aeruginosa (e) and C. albicans (f). Negative control (NC) was acquired after incubation
with 5% tryptic soy broth (TSB) in 0.85% NaCl. Positive control was acquired after incubation with 70%
isopropanol. Data represent means ±SEM (standard error of the mean) of five replicates. The levels of
significance are: ** p < 0.01, *** p < 0.001.
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What’s more, the real-time dynamic permeable trend was collected on three representative
microorganisms, S. aureus, E. coli and C. albicans (Figure 8). Coincident with the end-point results, the
efficiently complete permeabilization of Der-PS4 on S. aureus and E. coli was both 8 µM. However,
it’s worth noting that, although Der-PS4 exhibited identical permeable activities on these two
microorganisms, the entire penetration of S. aureus was accomplished in a relatively short period of
time. While, E. coli may require a little longer time to reach total penetration. For C. albicans, complete
permeable trend was achieved at around 90 min after incubation with Der-PS4 and neither 4 µM nor 8
µM of Der-PS4 could thoroughly disrupt the fungal cell membrane.
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Figure 8. The time-curve of cell-membrane permeabilized activities of Der-PS4 were performed on S. 
aureus (a), E. coli (b) and C. albicans (c) in a range of concentrations based on the results of end-point 
on 120 min. The fluorescence was measured every 15 min. Positive control was acquired after 
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2.6. Scanning Electron Microscopy (SEM) Characterisation
The membrane integrity and morphological changes of cells treated with Der-PS4 were investigated
by SEM. As shown in Figure 9a,c,e, it is clearly revealed that S. aureus, E. coli and C. albicans cells
display a smooth and distinct surface, however, the membrane of S. aureus, E. coli and C. albicans cells
were damaged dramatically in the presence of peptides. We observed that partial S. aureus, E. coli and
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C. albicans cells exhibited obvious irregularities, shrinkages, blebbing, and a budding surface after
treating with the Der-PS4 within 15 min, as in Figure 9b,d,f.
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2.7. ntiproliferative ctivity of er-PS4
The anticancer activity of Der-PS4 was evaluated on five human cell lines including U251MG,
MDA-MB-435S, H157, PC-3, MCF-7, which displayed does-dependent inhibitory activities in a range
of concentrations from 10−9 to 10−4 M (Figure 10). The anticancer activity of melittin is also shown
below as a relevant control. Overall, Der-PS4 showed more effective antiproliferative activity than
melittin on U251MG, MDA-MB-435S, and H157 cell lines and displayed a comparative effect on PC-3.
However, melittin exhibited a stronger inhibitory effect than Der-PS4 on MCF-7. The most effective
anti-proliferation activity of Der-PS4 was on the human glioblastoma astrocytoma cell line (U251MG),
with an IC50 value of 57.66 nM. Der-PS4 exhibited a similar potential against non-small cell lung
cancer (H157) and melanoma (MDA-MB-435S), with IC50 values of 0.19 and 0.11 µM. For breast cancer
(MCF-7) and prostatic cancer (PC-3), the inhibitory activities of Der-PS4 were relatively less effective,
with IC50 values of 0.67 and 0.44 µM. Additionally, the antiproliferative effect of Der-PS4 was also
examined on normal human cells, human dermal microvascular endothelium cells (HMEC-1). Der-PS4
showed slight inhibitory effect (IC50 0.46 M) compared to the potently inhibitory influence on cancer
cell lines.
The cell membrane integrity of cancer cell lines was tested by a lactate dehydrogenase (LDH)
cytotoxicity assay. Based on MTT results, cancer cells were exposed in a range of concentrations from
10−8 to 10−4 M. According to the results, displayed in Figure 11, MDA-MB-435S, H157 and PC-3 were
more sensitive to Der-PS4, with a significant difference at 10−5 and 10−4 M, while only 10−4 M of
Der-PS4 could disrupt the cell membranes of U251MG and MCF-7 and induce cell lysis.
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Figure 11. The lactate dehydrogenase (LDH) cytotoxicity results of Der-PS4 on five human cancer cell 
lines: U251MG (a), MDA-MB-435S (b), H157 (c), PC-3 (d) and MCF-7 (e). Each cell line was treated 
with Der-PS4 in a range of concentrations from 10−8 to 10−4 based on the results of MTT. Negative 
control was acquired after treated with serum-free culture medium. Positive control was acquired 
after treatment with lysis buffer supplied from Pierce LDH Cytotoxicity Assay Kit. Data represent 
means ± SEM (stand error of the mean) of five replicates. The levels of significance are: *** p < 0.0001. 
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3. Discussion
Antimicrobial peptides are widespread in most amphibian species. These cationic dermal peptides
are structurally diverse and express various levels of antimicrobial activities. Dermaseptins, one
family of amphibian antimicrobial peptides, including over 200 analogues known to date are widely
distributed in Hylidae frogs, especially in frogs of Phyllomedusinae [9]. In this study, we identified a
novel dermaseptin peptide named Der-PS4, using the same degenerate primer as previous reported,
from the skin secretions of Phyllomedusa sauvagii from which over 50 kinds of bioactive peptides were
discovered [17]. Considering Der-PS3 and Der-PS4 are identified in the same frog species (Phyllomedusa
sauvagii) [16], our results suggested that the signal peptide domain of precursor as well as the processing
site of dermaseptins peptides may provide a new approach in the classification of peptides. Although
dermaseptins are structurally multifarious, they share a typical conformation containing a tryptophan
at the third position, an -AA(A/G)KAA- consensus motif in the middle and an amide post-translational
modification at C-terminus [18]. This C-terminal amidation could increase the positive charge of
Der-PS4 and avoid degradation in the natural environment [19].
In recent decades, due to the overuse of antibiotics, drug-resistance has become an acute problem in
clinical treatment. Pandrug-resistant bacteria such as Pseudomonas aeruginosa, extensively drug-resistant
bacteria like Mycobacterium tuberculosis or multidrug-resistant bacteria such as methicillin-resistant
Staphylococcus aureus (MRSA), all these resistant pathogens cause serious infections and bring about
increasing mortality [20–23]. Der-PS4 exhibited a broad-spectrum of antimicrobial activities against
tested microorganisms including several resistant bacteria e.g., Gram-negative bacteria P. aeruginosa and
Gram-positive bacteria MRSA and E. faecalis, with MIC values of 16, 8 and 32 µM each. The inhibitory
concentrations against Gram-positive bacteria ranging from 4 to 32 µM seems slightly more efficient
than Gram-negative ones with MICs from 8 to 32 µM. Compared with the cell wall of Gram-positive
bacteria formed by peptidoglycan macromolecule constitutions, that of Gram-negative bacteria consist
of a lipid and lipopolysaccharides (LPSs) in outer membrane as well as a single peptidoglycan
layer. This distinction of bacterial envelope structure could be the predominant reason for different
MICs of Der-PS4 [24,25]. Considering the dermaseptins published before, like Dermaseptin-PH,
Der-PS4 showed stronger antimicrobial activities than Dermaseptin-PH did. The consensus motif
(-GKAAGKAA-) of Der-PS4 forming higher helicity than that (-GKAA-) of Dermaseptin-PH could be
one of the reasons. Moreover, the differences between the positively charged features of these two
peptides might also explain the stronger antimicrobial effect of Der-PS4. Hence, favourable helicity
and high cationic charge result in the noticeable antimicrobial efficiency of Der-PS4.
The biofilm inhibitory function of Der-PS4 correspond to the results of bacteria inhibitory assay
on the whole. The biofilm inhibitory concentrations against E. faecalis and P. aeruginosa were relatively
higher with 64 and 32 µM, respectively. This result might be due to the intrinsic resistance of these
two microorganisms [26,27]. Comparing the MBEC results of the five tested pathogens, it was
worthy of note that the biofilm of P. aeruginosa was most difficult to eradicate. It is well known that
P. aeruginosa isolates possess a strong inherent resistance owing to the low permeability of outer
membrane and notable adaptive mechanisms since biofilm forming [28,29]. These evidences may
explain the phenomenon that P. aeruginosa exhibited high resistance against Der-PS4 after the biofilm
formed with the eradication concentration at 256 µM. By a comparison of the results of MBEC and
MBC, it was discovered that the MBEC values were two to eight times higher than MBC values. It
is probably because the formation of biofilm could protect pathogens from external stimulations by
gathering the microorganisms from planktonic organisms to sessile communities [30]. Nowadays, the
mainstream of non-microbicidal methods include reducing attachment, inhibiting the formation of
biofilm to enhancing permeabilized ability of antimicrobial agents or preventing the maturation of
biofilm [31–34]. All these strategies focus on biofilm, which give a hint for the importance of biofilm
for the survival of pathogenic bacteria. Taking this into consideration, the eradication of biofilm
to prevent the formation of microbial communities provide new insights for the discovery of new
antimicrobial agents.
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Der-PS4 permeabilized the cell membrane of tested pathogens in two hours at low concentrations
less than their MIC values. With the increase of concentration, the penetrative ability of Der-PS4
improved rapidly. It is well known that the Val-Gly pairing in dermaseptins divide the peptide into
two segments forming a helix-hinge-helix structure, which can facilitate the hydrophobic residues
on both extremities to insert into membrane and induce permeabilization [35,36]. While, a novel
dermaseptin, named Dermaseptin-PH, discovered by Huang and co-workers, was a typical one without
Val-Gly segment. Compared with Dermaseptin-PH, Der-PS4 exhibited stronger antimicrobial and
penetrative activities [15]. Hence, perhaps the Val-Gly pairs within Der-PS4 was the reason why
Der-PS4 could permeabilize partial cell membrane of MRSA, E. faecalis and E. coli below the MICs. In
the dynamic-course figures, the penetrative procedure into the membrane could be observed clearly.
For bacterium S. aureus, although Der-PS4 could reach full permeabilization under both 8 and 16
µM, a relative quicker membrane-disruption occurred in fifteen minutes only at the concentration of
16 µM. A similar phenomenon could also be observed in E. coli and C. albicans, which implied that the
adsorption and disruption process between Der-PS4 and bacteria outer membrane took place quickly
under high concentrations of Der-PS4. Galanth and colleagues presented that once the accumulation
on membrane reached a threshold, the complex of positive charged peptides and anionic lipids could
form a positive curvature of the bilayer and the permeation/disruption happened under the carpet
mechanism [31]. These theories might explain the permeabilized results of Der-PS4, which induced
the rapid disruption of the bacteria cell membrane under a relatively high concentration, indicating the
accomplishment of a threshold concentration.
What’s more, Der-PS4 exhibited antiproliferative activity against five tested cancer cell lines and
showed slight cytotoxicity on normal human cells. Although quite a number of dermaseptins display
extensive cytotoxicity against tumour cells, it is still unclear what is the cellular selectivity or mechanism
of action. The dominant perception is that the electrostatic interaction between cationic antimicrobial
peptides and the anionic cancer cell membrane is the main reason [37]. The negative charged molecules
located on the cancer cell membrane, such as phosphatidylserine (PS), O-glycoslated mucins, and
glycosaminoglycans, play important roles for the interaction between the membrane and antitumour
peptides [38–41]. After accumulation on the tumour cell membrane by electrostatic interaction, the
peptides penetrate into the membrane and a membrane-disruption mechanism is induced followed by
cell lysis. These evidences might reveal the electrostatic incorporation mechanisms of Der-PS4, which
taken +3 net positive charge except the C-terminal amidation. However, the lactate dehydrogenase
(LDH) release assay tested on human cancer cell lines exhibited an interesting result that Der-PS4
displayed weak potency in disrupting cancer cell membranes although high concentrations of Der-PS4
displayed strong antiproliferative activities in MTT assay, which suggested that the reduction of
cell viability caused by Der-PS4 may not rely on membrane disruption but on other mechanisms.
Dermaseptin-PS1, discovered by Long and colleagues, inhibited cell growth under concentrations
ranging from 10−6 to 10−4 M. Whereas, only 10−5 and 10−4 M of Dermaseptin-PS1 could induce LDH
release and exhibited antiproliferative activities via the induction of intrinsic apoptosis signaling merely
at 10−6 M [42]. Der-PS4 could reduce cell viability ranging from 10−8 to 10−4 M while induced LDH
release at 10−5 and 10−4 M. Hence, it is reasonable to deduce that the anticancer mechanisms of Der-PS4
are the joint effect of both electrostatic interaction and other antineoplastic pathways depending on
different concentrations.
4. Materials and Methods
4.1. Acquisition of Phyllomedusa sauvagii Skin Secretions
The waxy monkey tree frogs, Phyllomedusa sauvagii, were fed with multivitamin-loaded crickets
three times per week in the new breeding environment for three months or more before the experiment.
All frogs were housed in separate under 12 h/12 h day/night cycles. The secretions were obtained after
the gentle transdermal electrical stimulation, and then washed by deionised water and collected in a
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glass beaker. Afterwards, the specimens were quick-frozen in liquid nitrogen and then lyophilised.
The products were kept at −20 ◦C prior to the next step [43]. The procedure was carried out based on
the guidelines in the UK Animal (Scientific Procedures) Act 1986, project license PPL 2694, issued by
the Department of Health, Social Services and Public Safety, Northern Ireland. The operational process
was supervised by the IACUC of Queen’s University Belfast, and authorized on 1 March 2011.
4.2. Molecular Cloning and Structural Characterisation of Der-PS4 from a Skin Secretion-Derived cDNA
Library of Phyllomedusa sauvagii
Five milligrams of lyophilised skin secretions were dissolved in 1ml lysis/binding buffer (Dynal
Biotech, Merseyside, UK) followed by isolation using a magnetized Dynabeads® mRNA DirectTM Kit
(Dynal Biotech, Merseyside, UK) based on A-T pairing. The isolated mRNA acted as a template and the
first strand of cDNA library was constructed using a SMART-RACE Kit (Clontech, Palo Alto, CA, USA).
Then the RACE-PCR was performed by using a nested universal primer (NUP) supplied from the kit as
antisense primer and the degenerate sense primer (S1; 5′-ACTTTCYGAWTTRYAAGMCCAAABATG-3′)
(Y = C/T; W = A/T; R = A/G’ M = A/C; B = T/C/G) which was designed based on nucleotide sequences
of the highly conserved signal peptide region of dermaseptin peptides published previously from
Phyllomedusa sauvagii. The PCR products were gel-electrophoresis analyzed and purified by using a
ConcertTM Rapid PCR Purification System (Life Technologies, Warrington, UK). Then the purified
products were cloned using a pGEM-T Easy Vector System (Promega Corporation, Southampton, UK)
and gel-electrophoresis analyzed followed by purification using the ConcertTM Rapid PCR purification
System. Finally, the sequencing reaction was carried out using a BigDye Terminator Sequencing Kit
(Applied Biosystems, Foster City, CA, USA). An ABI 3100 automated capillary sequencer (Applied
Biosystems, Foster City, CA, USA) was engaged to analyse the nucleotide sequence of selected
cloned products.
4.3. Identification and Structural Chracterisation of the Predicted Der-PS4 from the Skin Secretion of
Phyllomedusa sauvagii
Five milligrams of lyophilized skin secretions were dissolved in 1ml of water/trifluoracetic acid
(TFA) (99.95/0.05, v/v) and then centrifuged at 5000 rpm for 20 min. The supernatant was collected
and injected into an RP-HPLC system (Waters, Miford, MA, USA) loaded with a column (Jupiter C-18,
5 µM, 4.6 mm × 250 mm, Phenomenex, Macclesfield, Cheshire, UK). Samples were eluted with a linear
gradient mobile phase from water/trifluoracetic acid (TFA) (99.95/0.05, v/v) to acetonitrile/water/TFA
(80.00/19.95/0.05, v/v) at a flow rate of 1ml/min for 240 min. The absorbance was detected at 214 and
280 nm wavelength. The fractions were collected every minute and then analysed by MALDI-TOF
(matrix assisted laser dissociation ionized-time of flight) (Voyager DE, Perspective Biosystem, Foster
City, CA, USA) with CHCA (α-cyano-4-hydroxycinnamic acid) as matrix. Then, fractions containing
molecular mass coincident with the peptide identified from “shot-gun” cloning result were injected into
an LCQ-Fleet electrospray ion-trap mass spectrometer (Thermo Fisher Scientific, San Francisco, CA,
USA) to confirm the amino acid sequences of predicted mature peptide using MS/MS fragmentation
sequencing technique.
4.4. Solid-Phase Synthesis of Der-PS4
Dermaseptin-PS4 was synthesized using Fmoc (9-fluorenylmethyloxycarbonyl) solid-phase
chemistry synthesis technique using a Tribute® PS4 Peptide Synthesizer (Protein Technologies,
Tucson, AZ, USA). HBTU (2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate)
acted as an activator and peptides were deprotected from Fmoc protection groups using
dimethylformamide/piperidine (80/20, v/v). The cleavage process was carried out in a cocktail
consisted of TFA/thioanisole/H2O/1,2-ethanedithiol (94/2/2/2, v/v/v/v) at room temperature for maximum
120 min. Following that, peptides were washed using diethyl ether and dissolved in TFA/water
(99.95/0.05, v/v) before lyophilisation. The lyophilised products were purified using RP-HPLC and the
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purity result was identified by mass spectrometry. The purified products were stored at −20 ◦C before
bioactive assessment.
4.5. Secondary Structural Analysis of Der-PS4 through Circular Dichroism (CD) Spectroscopy
The second structure of Der-PS4 was analyzed by circular dichroism spectroscopy technique using
a JASCO J-815 CD spectrometer (Jasco, Essex, UK), as described previously [44]. Basically, synthesized
Der-PS4 was prepared at 50 µM in 10 mM ammonium acetate, TFE/10mM ammonium acetate (50/50,
v/v) and large unilamellar vesicles (LUVs) solutions for conformational study. Stock solutions of
DOPG, DOPC and DOPE (Avanti, Alabaster, AL, USA) were prepared at 1mg/mL in chloroform.
Desired proportions were mixed and evaporated using vacuum rotary evaporator (IKA, Staufen, DE)
and the residual solvent was removed in a vacuum chamber. The dried lipid film was collected and
dissolved in MiliQ water at PH 6.5. The LUVs were obtained after five cycles of freeze-thawing in liquid
nitrogen followed by extrusion through two stacks of 0.2 µM polycarbonate filters (Millipore Corp.,
Bedford, MA, USA) using a Liposofast low pressure homogenizer (Avestin, Ottawa, CA). The lipid
concentration of LUVs subjected to CD analysis was 0.5mM. Parameters were set as 1 nm bandwidth
and 0.5 nm data pitch and the data was recorded at a wavelength ranging from 190 nm to 260 nm
with a 200 nm/min scan speed. Secondary structure results were estimated by BESTSEL CD spectrum
analysis tool [45]. The structural parameters of Der-PS4 including physicochemical properties, polar
residues, nonpolar residues and helical wheel projections were acquired by analyzing on Heliquest
(http://heliquest.ipmc.cnrs.fr/).
4.6. Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) Assays
Gram-positive bacteria Staphylococcus aureus (NCTC 10788), methicillin-resistant Staphylococcus
aureus (MRSA) (NCTC 12493) and Enterococcus faecalis (NCTC 12697); Gram-negative bacteria Escherichia
coli (NCTC 10418) and Pseudomonas aeruginosa (ATCC 27853); fungus Candida albicans (NCYC 1467)
was inoculated in Mueller-Hinton broth (MHB) (Sigma-Aldrich, St. Louis, MO, USA) for sixteen to
eighteen hours. Then 500 µL of initial growth cultures were transferred into 20 mL MHB and cultured
in a shaking incubator at 37 ◦C until the microorganisms reaching logarithmic growth phases by testing
the optical density (OD) at 550 nm wavelength. After that, the subcultured microorganisms were
diluted by MHB until 1 × 106 colony forming units (cfu)/mL for bacteria and 1 × 105 cfu/mL for fungus
obtained. Then the microorganisms were cultured with Der-PS4 in a range of final concentrations
from 1 µM to 512 µM in a 96-well culture plate. The plate was incubated at 37 ◦C for sixteen to
eighteen hours in a humid atmosphere. The growth curve of each microorganism was determined by
means of measuring absorbance values at 550 nm wavelength in a Synergy HT plate reader (Biotech,
Minneapolis, MN, USA). The MIC value was defined as the lowest concentration of Der-PS4 at which
no obvious growth of each microorganism was observed. For the MBC assay, transfer 20 µL microbial
suspension from MIC to each higher concentration onto a Mueller-Hinton agar (MHA) (Sigma-Aldrich,
St. Louis, MO, USA) plate. After eighteen hours incubation at 37 ◦C, the MBC value was defined as
the lowest concentration of Der-PS4 at which no obvious colonies were observed.
4.7. Minimum Biofilm Inhibitory Concentration (MBIC) and Minimum Biofilm Eradication Concentration
(MBEC) Assays
Gram-positive bacteria S. aureus (NCTC 10788), MRSA (NCTC 12493) and E. faecalis (NCTC 12697)
were inoculated in tryptic soy broth (TSB) (Sigma-Aldrich, St. Louis, MO, USA) for sixteen to eighteen
hours at 37 ◦C in a shaking incubator at different revolutions per minute (rpm) according to different
bacteria. Gram-negative bacteria E. coli (NCTC 10418) and P. aeruginosa (ATCC 27853) were inoculated
in Luria-Bertani (LB) broth (Sigma-Aldrich, St. Louis, MO, USA) for sixteen to eighteen hours at 37 ◦C
in a shaking incubator at different revolutions per minute (rpm) according to different bacteria. Then
500 µL of initial growth cultures were transferred into 20 mL relevant broth and cultured in a shaking
incubator at 37 ◦C until the microorganisms reaching logarithmic growth phases by testing the OD at
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550 nm. After that, the subcultured microorganisms were diluted by relevant broth until 1 × 106 cfu/mL
density obtained and ready for subsequent assays. For the MBIC assay, each microorganism was
cultured with Der-PS4 in a range of final concentrations from 1 µM to 512 µM in a 96-well flat-bottom
culture plate. Plate was incubated at 37 ◦C in a humid atmosphere at relevant rpm. Sixteen to eighteen
hours later, the plate was washed twice by phosphate buffer saline (PBS) (Sigma-Aldrich, St. Louis,
MO, USA) and fixed with methanol for 10 min. For the MBEC assay, 100 µL of each microorganism
was transferred to a 96-well flat-bottom culture plate and incubated at 37 ◦C in a humid atmosphere
at relevant rpm. Sixteen to eighteen hours later, the plate was washed twice by PBS and re-cultured
with 100 µL Der-PS4 dissolved in relevant culture medium in a range of concentrations from 1 µM to
512 µM. Sixteen to eighteen hours after exposure, plate was washed twice again with PBS and fixed
with methanol for 10 min. Subsequently, 150 µL 0.1% (m/v) crystal violet solution was used to stain the
biofilm of both MBIC and MBEC plates. After 30 min, plates were washed by PBS until no obvious
crystal violet solution was observed. After evaporation of the stained plates, 100 µL 30% (v/v) acetic
acid were used to dissolve the stains and measured at 595 nm wavelength using a Synergy HT plate
reader (Biotech, Minneapolis, MN, USA). The MBIC value was defined as the minimum concentration
which inhibited the formation of biofilm over 90% compared to the negative control. The MBEC value
was defined as the minimum concentration which eradicated the formed biofilm over 90% compared
to the negative control [46].
4.8. Haemollysis Assay
Two millilitres defibrinated horse blood (TCS Biosciences Ltd., Botolph Clayton, UK) was
centrifuged at 1000× g for five minutes. Then, the supernatant was discarded and washed by PBS until
the supernatant was clear. The final supernatant was quitted and the blood cells were resuspended
by PBS until a concentration of 4% (v/v) obtained. Then, the resuspended cells were incubated with
Der-PS4 in a range of final concentrations from 1 µM to 512 µM at 37 ◦C for 2 h. After the exposure, the
mixtures were centrifuged at 1000× g for five minutes to collect supernatant and placed into a 96-well
plate. The absorbance was detected at 570 nm wave length by a Synergy HT plate reader (Biotech,
Minneapolis, MN, USA). Blood cells treated with 1% (v/v) Triton-X 100 (Sigma-Aldrich, St. Louis, MO,
USA) were used as positive control.
4.9. Bacteria Cell Membrane Permeability Assay
Each microorganism was inoculated in TSB (Sigma-Aldrich, St. Louis, MO, USA) for sixteen to
eighteen hours at 37 ◦C in a shaking incubator at different revolutions per minute (rpm) according to
different bacteria. Then 200 µL of initial growth cultures were transferred into 25 mL TSB and cultured
in a shaking incubator at 37 ◦C. 2.5 h later, the cultures were centrifuged at 1000× g at 4 ◦C for 10 min to
collect the bacteria and then washed twice by 30 mL 5% (v/v) TSB in 0.85% (m/v) sodium chloride (NaCl)
solution. Then, the washed bacteria were resuspended by 5% (v/v) TSB in 0.85% (m/v) NaCl solution
until a 1 × 108 cfu/mL density obtained by testing the OD at 590 nm wavelength. The microorganisms
were incubated with Der-PS4 in a range of concentrations based on MICs in a black 96-well flat bottom
plate at 37 ◦C for two hours. For the positive control, the microorganisms were incubated with 70%
(v/v) isopropanol at room temperature for 1 h and then centrifuged at 13,000 × g at 4 ◦C for 5 min. The
supernatant was discarded and the precipitate was washed twice by 5% (v/v) TSB in 0.85% (m/v) NaCl
solution and finally resuspended by 5% (v/v) TSB in 0.85% (m/v) NaCl solution. All groups were stained
by SYTOXTM green nucleic acid stain (Life technologies, Carlsbad, CA) to a final concentration of 5 µM
and incubated in dark at 37 ◦C for 5 min. The fluorescent intensity was detected by a Synergy HT plate
reader (Biotech, Minneapolis, MN, USA) with the excitation of 485 nm and emission of 528 nm.
For the time-curve bacteria cell membrane permeability assay, the microorganisms were processed
as described above until a 1 × 108 cfu/mL density obtained. After that, the positive control was treated
with 70% (v/v) isopropanol at room temperature for 1 h first, then washed twice and resuspended
by 5% (v/v) TSB in 0.85% (m/v) NaCl solution. All groups were incubated with SYTOXTM green stain
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(5 µM) for 15 min and subsequently were treated by Der-PS4 with final concentration of 4, 8 and 16 µM
respectively based on the results of last step. The fluorescent intensity was detected every 15 min for
120 min.
4.10. Scanning Electron Microscope (SEM) Characterisation
Bacterial cells were collected by centrifugation at 1000 ×g for 10 min, washed thrice with 0.1 M PBS
(pH = 7.4), and resuspended to an OD at 600 nm wavelength of 0.2 with PBS. Cells were incubated with
peptides at 37 ◦C for 15 min at their 1 ×MICs. The control was run without peptides. After incubation,
the cells were collected, washed with PBS three times and fixed with 2.5% (m/v) glutaraldehyde at
4 ◦C overnight. Then, cells were washed twice with PBS. The cells were dehydrated for 15 min in a
graded ethanol series, followed by 15 min in 100% ethanol, a mixture (1/1, v/v) of 100% ethanol and
tert-butanol, and absolute tert-butanol. Finally, the specimens were dehydrated in a critical point dryer
with liquid CO2, coated with gold–palladium, and then observed using a Hitachi SU8010 scanning
electron microscope (Hitachi, Tokyo, Japan).
4.11. MTT Cell Viability Assay
U251MG (ECACC-09063001), MCF-7 (ATCC-HTB-22) and MDA-MB-435s (ATCC-HTB-129)
were cultured in Dulbecco’s Modified Eagle Medium (DMEM) (Life technologies, Carlsbad, CA)
supplemented with 10% (v/v) fetal bovine serum (FBS) (Sigma-Aldrich, St. Louis, MO, USA) and 1% (v/v)
penicillin-streptomycin (Invitrogen, Paisley, UK). H157 (ATCC-CRL-5802) and PC-3 (ATCC-CRL-1435)
were cultured in Roswell Park Memorial Institute (RPMI)-1640 (Life technologies, Carlsbad, CA)
supplemented with 10% (v/v) FBS and 1% (v/v) penicillin-streptomycin. HMEC-1 (ATCC-CRL-3243)
was cultured in MCDB131 (Life technologies, Carlsbad, CA) supplemented with 10% (v/v) FBS, 1% (v/v)
penicillin-streptomycin, 10 ng/mL epidermal growth factor (EGF), 10 mM L-glutamine and 1 µg/mL
hydrocortisone. Cells were grown in a 96-well flat-bottom culture plate in a density of 3000 cells
per well. After 24 h, cells were treated with relevant culture medium without FBS and cultured for
12 h. Then, cells were treated with Der-PS4 in a range of concentrations from 10−9 to 10−4 M for 24 h.
Subsequently, MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphehyltetrazolium Bromide) was added to each
well to a final concentration of 0.5 mg/mL and incubated at 37 ◦C. Six hours after exposure, mixtures
in each well were discarded and 100 µL DMSO was added. The absorbance was detected at 570 nm
wavelength using a Synergy HT plate reader (Biotech, Minneapolis, MN, USA).
4.12. Lactate Dehydrogenase (LDH) Cytotoxicity Assay
Cells were cultured as described in Section 4.10. Cells were grown in a 96-well flat-bottom culture
plate in density of 3000 cells per well and treated with 10−9 to 10−4 M of Der-PS4 for 24 h. Cells
treated with lysis buffer supplied from Pierce LDH Cytotoxicity Assay Kit (Thermo Fisher Scientific,
Loughborough, UK) at 37 ◦C for 45 min were acted as maximum LDH activity controls. Then 50 µL
cultured medium were mixed with 50 µL reaction mixture at room temperature for 30 min keeping in
a dark place. Subsequently, 50 µL stop solution was added by gentle pipetting. The absorbance was
measured at 490 nm and 680 nm wavelength respectively using a Synergy HT plate reader (Biotech,
Minneapolis, MN, USA).
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Abbreviations
The following abbreviations were used in this manuscript:
RP-HPLC reverse-phase high-performance liquid chromatography
SPPS solid-phase peptide synthesis
CD circular dichroism
TFE 9-fluorenylmethyloxycarbonyl
SEM scanning electron microscopy
MTT 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide
LDH lactate dehydrogenase
RACE-PCR rapid amplification of cDNA ends-polymerase chain reaction
NUP nested universal primer
TFA trifluoracetic acid
MALDI-TOF matrix-assisted laser desorption/ionization time-of-flight
CHCA α-cyano-4-hydroxycinnamic acid
Fmoc 9-fluorenylmethyloxycarbonyl
HBTU 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate
OD optical density
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